Lyons, CO, United States of America

Ryan Dregalla

This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignees: Elite I.p., Inc., Lucina Patent Holdco, LLC, Napa Medical Research Foundation. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ryan Dregalla. Retrieved from https://idiyas.com/inventor/ryan-dregalla-lvy35spg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 3.7

ph-index = 1


Company Filing History:


Years Active: 2022-2026

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Ryan Dregalla in Mesenchymal Stem Cell Harvesting

Introduction

Ryan Dregalla is an accomplished inventor based in Lyons, Colorado, known for his significant contributions to the field of medical technology. He holds three patents that focus on improving the efficiency of mesenchymal stem cell harvesting, a critical area in regenerative medicine. His work aims to enhance the collection and processing of physiological fluids containing these valuable cells.

Latest Patents

Dregalla's latest patents include a method and apparatus for improved mesenchymal stem cell harvesting. This innovative system increases the efficiency of collecting and processing physiological fluids from a cavity within a patient's skeletal system. The process involves penetrating microenvironments within the patient's ilium using a pointed instrument to create an aperture in the hard cortical bone. Following this, an aspiration device is inserted to extract samples of cancellous bone, bone marrow, and other aspirated materials. The aspirate is then rinsed and filtered to remove unwanted material, significantly increasing the concentration and purity of mesenchymal stem cells for autologous treatment.

Career Highlights

Throughout his career, Ryan Dregalla has worked with notable organizations such as Elite IP, Inc. and Napa Medical Research Foundation. His experience in these companies has allowed him to refine his skills and contribute to advancements in medical technology.

Collaborations

Dregalla has collaborated with professionals like Edward Jeffrey Donner and Christopher Thomas Donner, enhancing his work through shared expertise and innovative ideas.

Conclusion

Ryan Dregalla's contributions to mesenchymal stem cell harvesting represent a significant advancement in medical technology. His innovative methods and dedication to improving patient care continue to influence the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…